These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8842847)

  • 21. [Catamnestic study on the efficacy of an intensive outpatient treatment programme for alcohol-dependent patients: impact of participation in AA on the abstinence rates].
    Bottlender M; Soyka M
    Fortschr Neurol Psychiatr; 2005 Mar; 73(3):150-5. PubMed ID: 15747224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment for substance abuse in Australia: a comparison of public and private programs.
    McNeese-Smith DK
    Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women's programs versus mixed-gender day treatment: results from a randomized study.
    Kaskutas LA; Zhang L; French MT; Witbrodt J
    Addiction; 2005 Jan; 100(1):60-9. PubMed ID: 15598193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a stimulant-focused enhanced program on the outcome of alcohol- and/or stimulant-dependent men.
    Smith TL; Volpe FR; Hashima JN; Schuckit MA
    Alcohol Clin Exp Res; 1999 Nov; 23(11):1772-9. PubMed ID: 10591593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of short-term treatment outcomes among California's Proposition 36 participants.
    Hser YI; Evans E; Teruya C; Huang D; Anglin MD
    Eval Program Plann; 2007 May; 30(2):187-96. PubMed ID: 17689324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of treatment options for alcohol-abusing workers.
    Walsh DC; Hingson RW; Merrigan DM; Levenson SM; Cupples LA; Heeren T; Coffman GA; Becker CA; Barker TA; Hamilton SK
    N Engl J Med; 1991 Sep; 325(11):775-82. PubMed ID: 1870651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in outcomes in an HMO-based substance abuse treatment program.
    Green CA; Polen MR; Lynch FL; Dickinson DM; Bennett MD
    J Addict Dis; 2004; 23(2):47-70. PubMed ID: 15132342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social phobia in an outpatient alcohol and drug treatment sample.
    Adamson SJ; Sellman JD; Robertson PJ
    Aust N Z J Psychiatry; 2008 Feb; 42(2):134-40. PubMed ID: 18197508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of opiate users leaving detoxification treatment against medical advice.
    Kenne DR; Boros AP; Fischbein RL
    J Addict Dis; 2010 Jul; 29(3):383-94. PubMed ID: 20635287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spirituality, sense of coherence, and coping responses in women receiving treatment for alcohol and drug addiction.
    Arévalo S; Prado G; Amaro H
    Eval Program Plann; 2008 Feb; 31(1):113-23. PubMed ID: 17825910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a residential program using the Addiction Severity Index and stages of change.
    Campbell WG
    J Addict Dis; 1997; 16(2):27-39. PubMed ID: 9083823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment dropouts: characteristics and outcomes.
    Gottheil E; Sterling RC; Weinstein SP
    J Addict Dis; 1997; 16(2):1-14. PubMed ID: 9083821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating primary medical care with addiction treatment: a randomized controlled trial.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
    JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term alcohol and drug treatment outcomes predict long-term outcome.
    Weisner C; Ray GT; Mertens JR; Satre DD; Moore C
    Drug Alcohol Depend; 2003 Sep; 71(3):281-94. PubMed ID: 12957346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised clinical trial of in-patient versus combined day hospital treatment of alcoholism: primary and secondary outcome measures.
    Weithmann G; Hoffmann M
    Eur Addict Res; 2005; 11(4):197-203. PubMed ID: 16110227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adolescent chemical dependency treatment in an HMO.
    Freeborn DK; Beaudet MP; Mullooly JP; Boehm RD; Brenes J
    HMO Pract; 1991; 5(2):44-50. PubMed ID: 10170804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A field application of the ASAM placement criteria in a 12-step model of treatment for chemical dependency.
    May WW
    J Addict Dis; 1998; 17(2):77-91. PubMed ID: 9567227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of an outpatient program for women with substance use-related disorders on retention.
    Zilberman ML; Tavares H; Andrade AG; El-Guebaly N
    Subst Use Misuse; 2003 Dec; 38(14):2109-24. PubMed ID: 14677784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.